إشكالية تحقيق مناعة القطيع ضد فيروس كوفيد 19 في الجزائر

Abstract EN

Through this study we aim to answer the problems of the development of vaccination against COVID-19 in Algeria.

and provide a brief definition of the most important vaccines against COVID-19 and their side effects.

in addition, we presented our most important findings in our study, namely the rate of complete vaccination estimated at 15% from the beginning of the operation until the date of 18 June 2022.

the latter is very weak compared to the ministry of health's projections that approximately 70% of the groups involved must be vaccinated to achieve herd immunity.

in this article, we relied on the exploitation of reports received from the world health organization (who) as well as the Algerian ministry of health daily and on the statistics of the website called our world in data (one of the most important sites producing data on COVID).

it is worth mentioning that this study is based primarily on the quantitative approach to its ability to accurately describe the evolution of the spread of COVID-19 by using the method of collecting and analysing data from the reports mentioned above.